Escalating therapy of cutaneous side effects of EGFR inhibitors: experience of German reference centers.
J Dtsch Dermatol Ges
; 10(8): 559-63, 2012 Aug.
Article
em En, De
| MEDLINE
| ID: mdl-22672156
ABSTRACT
Recommendations for the management of cutaneous adverse effects of inhibitors of the epidermal growth factor receptor (EGFR) are urgently needed. In this context an expert panel of German dermatologists recently proposed a 3-step management concept based on personal experience and a current literature consensus. While steps 1 and 2 addressed general and preventive measures, as well as the therapy that can be performed by the primary treating physician, here we address the management of challenging cases (step 3) that do not respond well to basic measures and should be referred to an experienced dermatologist.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Guias de Prática Clínica como Assunto
/
Toxidermias
/
Inibidores de Proteínas Quinases
/
Dermatologia
/
Receptores ErbB
Tipo de estudo:
Clinical_trials
/
Guideline
Limite:
Humans
País como assunto:
Europa
Idioma:
De
/
En
Ano de publicação:
2012
Tipo de documento:
Article